Navigation Links
Experts Explore Federal Agency Collaborations to Close Alzheimer’s Disease Research Gaps at ACT-AD Coalition Annual Meeting
Date:11/16/2016

Today, senior representatives from the U.S. Food and Drug Administration (FDA) and the National Institute on Aging (NIA) at the National Institutes of Health (NIH) joined with advocates, federal colleagues, researchers, and industry to explore collaborations for advancing the most up-to-date knowledge in Alzheimer’s disease research into clinical trials at the ACT-AD Coalition's Ninth Annual FDA/Alzheimer’s Disease Allies Meeting in North Bethesda, Md.

The theme of this year’s meeting was "Starting with the End in Mind: Aligning the Science to Close Gaps in Alzheimer’s Disease Therapeutic Development."

“Our 2015 ACT-AD meeting focused on the state of research, including existing gaps, into the underlying causes of Alzheimer’s disease and the pathways for successful treatment. This year, we picked up where that meeting left off,” says ACT-AD Executive Director Cynthia Bens. “At our meeting today, attendees held a frank discussion on whether NIH research is on track to help definitively close knowledge gaps identified by the FDA that will promote more successful therapeutic development. The consensus is that we have made significant strides, but we need to continue to refine strategies that increase research collaborations between government agencies, researchers, advocates, and industry. We look forward to continuing to build on the progress we made today.”

The main areas of focus at the meeting included: the most recent research on Alzheimer’s disease pathology and genetics; efforts to identify reliable biomarkers in treatment trials and advance novel biomarkers; and symptomatic approaches to improve treatment of major behavioral and psychiatric aspects of the disease.

The meeting featured a trio of expert presentations:

  • NIH Initiatives to Inform Alzheimer’s Disease Therapeutic Development, Richard Hodes, M.D., National Institute on Aging
  • Genetic and Biomarker Advances from Clinical Trials in Early Alzheimer’s Disease, Carole Ho, M.D., Denali, and Vissia Viglietta, M.D., Ph.D., Biogen
  • Findings from Current Trials Treating Behavioral and Psychiatric Symptoms of Alzheimer’s Disease, Paul Rosenberg, M.D., Johns Hopkins University

Also, a distinguished panel of experts explored the scientific and regulatory considerations for developing meaningful disease-modifying and symptomatic Alzheimer’s disease treatments.

ACT-AD and its partners will provide a more detailed summary of the results of today’s meeting at a future date. For more information, please visit the coalition’s meeting webpage or call 202-688-1229.

About ACT-AD

ACT-AD is a coalition of more than 50 national organizations representing patients, providers, caregivers, consumers, older Americans, researchers, and employers seeking to accelerate development of potential cures and treatments for Alzheimer's disease. The coalition is directed by an Advisory Council made up of representatives from the Alliance for Aging Research (AAR), Alzheimer's Foundation of America (AFA), American Society on Aging (ASA), National Alliance for Caregiving (NAC), National Association of Area Agencies on Aging (n4a), National Consumers League (NCL), Research!America, and the Society for Women's Health Research. The coalition is sponsored in part by Alkermes, Anavex, Avanir, Axovant, Biogen Idec, Eli Lilly, Genentech, Janssen, Lundbeck, Merck, and Novartis.

Read the full story at http://www.prweb.com/releases/2016/11/prweb13854721.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Salar Joins Medical Informatics Experts to Judge AMIA’s First Ever Student Design Challenge: Reinventing Clinical Documentation
2. Sublime Beauty® Reveals the "Work-Horse" of Anti-Aging Skin Care According to Dermatologists and Experts
3. Heartland Institute Experts React to President Obama’s Announcement about the Affordable Care Act
4. Medical Experts Gather at Cleveland Clinic Lou Ruvo Center for Brain Health for Annual Silverado Medical Director Conference
5. As a Record Number of Seniors Are Living Alone, Aging Experts Offer 7 Warning Signs to Look for on Thanksgiving Visits to Older Family Members and Friends
6. Noted Experts to Lead Breakthrough Conversation at Center for Hispanic Leadership, December 2nd Hispanics in Healthcare Forum
7. The Dentist's Network Launches New Website and Expands Panel of Experts
8. Tufts experts named Fellows by American Association for the Advancement of Science
9. Quality of Healthcare Experts Continue To Try To Put A Square Peg Into A Round Hole
10. Nutrition experts explore dietary approaches that influence type 2 diabetes risk
11. Pediatric HIV/AIDS experts to present at 17th Intl Conference on AIDS and STIs in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... 2017 , ... Talented host, actor Rob Lowe, is introducing ... new episode of "Success Files," which is an award-winning educational program broadcasted on ... subject in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Software and Consulting, LLC , and named its founder ... based in Tennessee , will operate ... expands EnvoyHealth,s service offerings for health care partners to ... "In an interoperable world, technology ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
Breaking Medicine Technology: